Skip to content
Because every patient has the right to expect treatment
English
Menu
English
About CTRS
Our company
The president’s words
Our team
Your health
Multiple myeloma
Primary bile acid synthesis disorders
Our products
Our R&D
Menu
About CTRS
Our company
The president’s words
Our team
Your health
Multiple myeloma
Primary bile acid synthesis disorders
Our products
Our R&D
News
Contact
Menu
News
Contact
English
Menu
English
About CTRS
Our company
The president’s words
Our team
Your health
Multiple myeloma
Primary bile acid synthesis disorders
Our products
Our R&D
News
Contact
Menu
About CTRS
Our company
The president’s words
Our team
Your health
Multiple myeloma
Primary bile acid synthesis disorders
Our products
Our R&D
News
Contact
News
About CTRS
Our company
The president’s words
Our team
Your health
Multiple myeloma
Primary bile acid synthesis disorders
Our products
Our R&D
News
Contact
Menu
About CTRS
Our company
The president’s words
Our team
Your health
Multiple myeloma
Primary bile acid synthesis disorders
Our products
Our R&D
News
Contact
Launch of Exploring (rare) cholestasis
March 17, 2021
Read more
Passing of Christian Cailliot, Director of R&D
March 8, 2021
Read more
Rare disease day at CTRS
February 28, 2021
Read more
CTRS is part Growth Champions 2021!
February 5, 2021
Read more
Partnership between CTRS and Unicancer
December 17, 2020
Read more
Repositioning drugs: a real opportunity for rare diseases?
December 15, 2020
Read more
« previous
Page
1
Page
2
Page
3
Next »